Podcast 20 Sep 2024Estonia’s biobank: Is this the first large-scale personalized medicine initiative? Estonia is working on becoming the first country to implement personalized health at scale through the Estonian National Biobank. September 20, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 13 Sep 2024Targeting inflammation: A revolution in disease treatment NLRP3 inflammasome-induced inflammation is at the root of nearly all disease pathologies. Listen to our conversation with Halia Therapeutics about it. September 13, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 12 Sep 2024New treatments being developed for schizophrenia Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials. September 12, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 6 Sep 2024The power of tumor infiltrating lymphocytes to fight melanoma Listen to our conversation with Brian Gastman, EVP of medical affairs at Iovance Biotherapeutics, about TILs and the company’s pipeline. September 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 30 Aug 2024The future of combination vaccines To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna. August 30, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 23 Aug 2024New German biotech spins out to develop radiotherapeutics While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company August 23, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 16 Aug 2024Challenging the European biotech funding status quo Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin. August 16, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 9 Aug 2024Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi. August 9, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 2 Aug 2024Rebroadcast: How does AI assist drug discovery? Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS. August 2, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 26 Jul 2024The first mass-market cell therapy? Listen to our conversation with CEO Greg Kunst about how Aurion’s treatment could be the first mass-market cell therapy available July 26, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 19 Jul 2024Cutting through the AI hype in drug discovery There’s certainly hype around AI, but what can it really do in drug discovery? Listen to our conversation with LabGenius to find out. July 19, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 12 Jul 2024How biotechs are revolutionizing acute on-chronic liver failure? Listen to our conversation with Genfit, a late-stage biopharma tackling acute on-chronic liver failure. July 12, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More